Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Relation of alleles of the collagen type I alpha 1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women

Article Abstract:

Variations in a gene for a type of bone matrix collagen may cause a decrease in bone mineral density and increase the risk of osteoporosis-related fractures in older women. Researchers analyzed the COLIA1 gene in 1,778 postmenopausal women, and found that particular variations were associated with 2% to 6% reductions in bone mineral density and higher rates of bone fractures. Among the oldest women tested, bone density was reduced as much as 20% in those with the least-favorable variation, compared with those with the most-favorable variation.

Author: Pols, Huibert A.P., Hofman, Albert, Ralston, Stuart H., Uitterlinden, Andre G., Leeuwen, Johannes P.T.M. van, McGuigan, Fiona E.A., Grant, Struan F.A., Burger, Huibert, Huang, Qiuju, Yue, Fang
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1998
Bones, Genetic aspects, Bone density, Postmenopausal women

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Homocysteine as a predictive factor for hip fracture in older persons

Article Abstract:

A study conducted to examine the linkage between the total homocysteine concentration and the risk of hip fracture in men and women enrolled in the Framingham Study, is presented. The results suggest that the homocysteine concentration is an important risk factor for hip fracture in older persons.

Author: Cupples, L. Adrienne, Kiel, Douglas P., Jacques, Paul F., Selhub, Jacob, McLean, Robert R., Tucker, Katherine L., Samelson, Elizabeth J., Broe, Kerry E., Hannan, Marian T.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2004
Aged, Elderly, Hip fractures

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Homocysteine levels and the risk of osteoporotic fracture

Article Abstract:

A study conducted to find out the relation between circulating homocysteine and the risk of incident osteoporotic fracture is presented. According to the results, increased homocysteine level appears to be a strong and independent risk factor for osteoporotic fractures in older men and women.

Author: Hofman, Albert, Witteman, Jacqueline C.M., de Groot, Lisette C.P.G.M., van Meurs, Joyce B. J., Dhonukshe-Rutten, Rosalie A. M., Pluijm, Saskia M. F., van der Klift, Marjolein, de Jonge, Robert, Lindemans, Jan, van Leeuwen, Johannes P.T.M.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2004

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Health aspects, Osteoporosis, Fractures (Injuries), Fractures, United States, Risk factors, Demographic aspects, Amino acids, Homocysteine
Similar abstracts:
  • Abstracts: Comparison of the effect of raloxifene and continuous-combined hormone therapy on mammographic breast density and breast tenderness in postmenopausal women
  • Abstracts: Effects of estrogen therapy on hearing in postmenopausal women
  • Abstracts: Nurse regulation in the spotlight. An era of opportunity for nursing entrepreneurs. Inquiry turns spotlight on elder abuse
  • Abstracts: Get tough on medical errors, conference told. School debt helps drive students into specialty matches. Minority mistrust still haunts medical care
  • Abstracts: Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.